H.C. Wainwright analyst raises Oric Pharmaceuticals price target to $25, expects catalyst-rich year ahead. Claim 50% off TipRanks Premium for hedge fund-level data and powerful investing tools. Stay informed with the latest news and analysis to maximize your portfolio’s potential. Source: TheFly, ultimate real-time financial news provider. See Insiders’ Hot Stocks on TipRanks, read more on ORIC. Oric Pharmaceuticals price target raised to $17 from $16 at Citi. Oric Pharmaceuticals launches new 2026 ATM Share Program, reports Q4 EPS (30c) vs. consensus (37c). Oric Pharmaceuticals expects cash to fund operations into 2H 2028, announces upcoming milestones.

Read more at Yahoo Finance: Oric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright